Ad
related to: pfizer, drugs industry
Search results
Paxlovid Fails to Quell Long Covid Symptoms in Stanford Study
Bloomberg· 21 hours agoA 15-day course of Pfizer Inc.’s antiviral Paxlovid didn’t provide significant relief for long Covid...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 22 hours agoThe biotech group ranks No. 40 out of 197 industry groups that IBD tracks. Meanwhile, the pharma...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 1 day agoSo, MRNA stock ranks narrowly inside the top half of all stocks, regardless the industry group, on...
AbbVie's tight grip on Humira market raises concerns about biosimilars
Colorado Springs Gazette· 1 day agoHumira, which lists for almost $7,000 a month, is the first top-selling drug to compete with a slew of biosimilars, which are close but not exact copies of branded biologic ...
2 High-Yield Dividend Stocks to Buy Right Now
The Motley Fool via AOL· 3 days agoPfizer: A robust yield at a bargain-basement price For those who are steadfast long...the next 10 to 20 years. Pfizer is a leading player in the global...
Germany’s Merck Bets on AI Drug-Design Partnerships, Rules Out Acquisitions – Interview
The Wall Street Journal· 1 day agoMerck—known as EMD Group in the U.S.— is betting on artificial-intelligence partnerships to develop...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 23 hours agoShares continued to climb, hitting a recent intraday high at 23.86 on June 6. Shares now have a top...
NJ health care, pharmaceutical companies cutting jobs as tech disrupts industry
The Bergen Record via Yahoo News· 1 day ago“This shift is also due to changes in research and development, drug failures, the end of...
AbbVie (ABBV) Starts Late-Stage Study on Multiple Myeloma Drug
Zacks via Yahoo Finance· 2 days agoThe late-stage study will evaluate AbbVie's (ABBV) experimental antibody to treat patients with...
AbbVie's (ABBV) Ovarian Cancer Therapy Meets Study Goal
Zacks via Yahoo Finance· 1 day agoData from a mid-stage study shows that treatment with AbbVie's (ABBV) Elahere achieves an objective...